JP EQUITY · SINGLE-STOCK DEEP DIVE · 良品計画

료힌케이카쿠(무인양품)(良品計画) — 유통 — 생활잡화·의류(무인양품)Ryohin Keikaku (MUJI) (良品計画) — Retail — lifestyle goods & apparel (MUJI)良品計画 — 小売 — 生活雑貨・衣料品(無印良品)

EDINET 有価証券報告書 FY2015~FY2025 를 이어 붙인 공통 재무 점검. 매출 3,075 → 7,846억엔, 영업이익률 11.2% → 9.4%, ROIC 22.1% → 20.6%. 손익 엔진·현금·운전자본·자본 배분·장부 점검·밸류에이션, 그리고 이 주가가 이익(P/E)을 따라가는지 장부(P/B)에 묶였는지를 같은 틀로 잰다. 방향은 단정하지 않는다.A common financial check built by linking EDINET annual securities reports for FY2015~FY2025. Revenue 3,075 → 7,846 JPY 100mn, operating margin 11.2% → 9.4%, ROIC 22.1% → 20.6%. The profit engine, cash, working capital, capital allocation, accounting checks and valuation — and whether this share price tracks earnings (P/E) or is anchored to book value (P/B) — are measured with the same frame. No view on direction is taken.EDINETの有価証券報告書FY2015~FY2025をつなぎ合わせた共通の財務点検。売上高3,075 → 7,846億円、 営業利益率11.2% → 9.4%、ROIC 22.1% → 20.6%。 損益エンジン・現金・運転資本・資本配分・帳簿点検・バリュエーション、そしてこの株価が利益(P/E)に連動するのか簿価(P/B)に縛られているのかを同じ枠組みで測る。方向は断定しない。

FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 회계기준 Japan GAAP. 기말 주가·시가총액·P/B 는 그해 有報의 EPS × PER 로 역산한 가공값(적자 해는 PER 미기재로 빈칸). 분기보고서는 2024년 4월 폐지 — 그 뒤는 반기뿐이다.FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). Accounting standard: Japan GAAP. Year-end share prices, market cap and P/B are derived values back-calculated as EPS × P/E from that year’s annual securities report (loss years are blank because P/E is not reported). Quarterly securities reports were abolished in April 2024 — after that there are only half-year figures.FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 会計基準日本基準。 期末株価・時価総額・P/Bはその年の有報のEPS × PERから逆算した加工値(赤字の年はPER記載なしのため空欄)。 四半期報告書は2024年4月に廃止 — それ以降は半期のみ。
매출 FY2025Revenue FY2025売上高 FY20257,846억엔7,846 JPY 100mn7,846億円FY2015 3,075억엔FY2015 3,075 JPY 100mnFY2015 3,075億円
영업이익률Operating margin営業利益率9.4%FY2015 11.2%
ROIC(영업 투하자본)ROIC (operating invested capital)ROIC(営業投下資本)20.6%고점 FY2017 27.1%Peak FY2017 27.1%ピーク FY2017 27.1%
안전마진Margin of safety安全余裕率17.3%영업 레버리지 5.79배Operating leverage 5.79x営業レバレッジ5.79倍
누적 FCFCumulative FCF累計FCF1,945억엔1,945 JPY 100mn1,945億円FY2015~FY2025
P/B (가공)P/B (derived)P/B(加工値)5.10배5.10x5.10倍범위 1.42~5.66Range 1.42~5.66範囲1.42~5.66
P/E33.2배33.2x33.2倍배당수익률 1.57%Dividend yield 1.57%配当利回り1.57%
P/E 냐 P/B 냐P/E or P/BP/EかP/Bかβ 1.50이익을 따라감Tracks earnings利益に連動

① 손익 패널Income statement panel損益パネル — FY2015~FY2025

억엔 · 비율 = 매출 대비 % · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).JPY 100mn · ratios = % of revenue · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).億円 · 比率 = 売上高比% · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). · Data as of 2025-08-31 · Created 2026-11-01
FY매출Revenue売上高매출총이익률Gross margin売上総利益率판관비율SG&A ratio販管費率연구개발/매출R&D/revenue研究開発費/売上高영업이익Operating profit営業利益영업이익률Operating margin営業利益率경상이익Ordinary profit経常利益특별손익Extraordinary items特別損益순이익Net profit純利益특별 제외 순이익Net profit ex. extraordinary items特別損益除く純利益ROE
20153,07548.9%37.7% 0.3%34411.2%327 8217 21215.6%
20163,33349.8%38.3% 0.4%38311.5%386 1258 25817.7%
20173,79650.5%38.6% 0.4%45311.9%460 -8301 30718.6%
20184,09751.6%40.7% 0.3%44710.9%459 80338 28818.8%
20194,38749.6%41.3% 0.3%3648.3%364 -18233 24411.8%
20201,79446.7%46.2% 0.3%90.5%6 -187-169 -40-8.8%
20214,53749.0%39.6% 0.2%4249.4%454 32339 31717.3%
20224,96247.2%40.6% 0.2%3286.6%372 -40246 27610.8%
20235,81446.7%41.0% 0.2%3315.7%362 -24221 2368.7%
20246,61750.8%42.4% 0.3%5618.5%558 41416 38714.9%
20257,84651.4%41.9% 0.2%7389.4%723 -63508 55716.3%
매출은 FY2015 3,075억엔에서 FY2025 7,846억엔(연 9.8%), 영업이익률은 11.2% → 9.4%. 특별 제외 순이익 = 순이익 − 특별손익 × (1 − 그해 실효세율). 2024-04 四半期報告書 폐지로 2024년 하반기부터는 반기만 있다 .Revenue went from 3,075 JPY 100mn in FY2015 to 7,846 JPY 100mn in FY2025 (9.8% a year); operating margin 11.2% → 9.4%. Net profit ex. extraordinary items = net profit − extraordinary items × (1 − that year's effective tax rate). With quarterly securities reports abolished in April 2024, only half-year figures exist from the second half of 2024 .売上高はFY2015の3,075億円からFY2025の7,846億円(年率9.8%)、営業利益率は11.2% → 9.4%。 特別損益除く純利益 = 純利益 − 特別損益 ×(1 − その年の実効税率)。2024年4月の四半期報告書廃止により、2024年下期からは半期のみ 。

② 비용 구조 — 매출 1엔이 어디로 가나Cost structure — where each yen of revenue goesコスト構造 — 売上1円はどこへ行くか

매출 대비 %% of revenue売上高比% · Data as of 2025-08-31 · Created 2026-11-01
매출원가율 FY2015 51.1% → FY2025 48.6% · 판관비율 37.7% → 41.9% · 연구개발/매출 0.3% → 0.2% · 감가상각/매출 1.8% → 3.2%. 판관비는 손익계산서 합계(판매비·일반관리비 구분 없음), 연구개발비는 주석의 총액(판관비 안 포함분), 감가상각은 현금흐름표 합계라 다른 선과 겹친다 — 더하면 안 된다.Cost-of-sales ratio FY2015 51.1% → FY2025 48.6% · SG&A ratio 37.7% → 41.9% · R&D/revenue 0.3% → 0.2% · depreciation/revenue 1.8% → 3.2%. SG&A is the income-statement total (no split between selling and G&A expenses); R&D is the total from the notes (including the part within SG&A) and depreciation is the cash-flow-statement total, so they overlap with the other lines — do not add them up.売上原価率FY2015 51.1% → FY2025 48.6% · 販管費率37.7% → 41.9% · 研究開発費/売上高0.3% → 0.2% · 減価償却費/売上高1.8% → 3.2%。 販管費は損益計算書の合計(販売費・一般管理費の区分なし)、研究開発費は注記の総額(販管費に含まれる分を含む)、減価償却費はキャッシュ・フロー計算書の合計のため、他の線と重複する — 足し合わせてはならない。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 판관비 구분·연구개발비·감가상각은 원문 계정 그대로라 서로 겹친다(연구개발비는 판관비·제조원가 안에, 감가상각은 현금흐름표 합계) — 더하면 안 된다. 세로축은 로그 눈금.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: The SG&A breakdown, R&D and depreciation follow the original accounts and overlap (R&D sits inside SG&A and manufacturing cost; depreciation is the cash-flow-statement total) — do not add them up. The vertical axis is on a log scale.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 販管費の内訳・研究開発費・減価償却費は原文の勘定科目のままで互いに重複する(研究開発費は販管費・製造原価の中、減価償却費はキャッシュ・フロー計算書の合計)— 足し合わせてはならない。縦軸は対数目盛。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

③ 손익 엔진 — 고정비가 얼마나 무거워졌나Profit engine — how much heavier fixed costs have become損益エンジン — 固定費はどれだけ重くなったか

억엔 · % · 계정 분류(勘定科目法)JPY 100mn · % · account-classification method億円 · % · 勘定科目法 · Data as of 2025-08-31 · Created 2026-11-01
안전마진 — 매출이 몇 % 빠지면 영업적자인가Margin of safety — how far revenue can fall (%) before an operating loss安全余裕率 — 売上が何%減ると営業赤字か
FY201522.1%
FY202517.3%
손익분기 매출 2,397 → 6,492억엔Break-even revenue 2,397 → 6,492 JPY 100mn損益分岐点売上高2,397 → 6,492億円
고정비(판관비 + 감가상각)Fixed costs (SG&A + depreciation)固定費(販管費 + 減価償却費)
FY20151,216억엔1,216 JPY 100mn1,216億円
FY20253,540억엔3,540 JPY 100mn3,540億円
공헌이익률 50.7% → 54.5%Contribution margin 50.7% → 54.5%限界利益率50.7% → 54.5%
영업 레버리지 — 매출 1% 변화 → 영업이익 몇 %Operating leverage — % change in operating profit per 1% change in revenue営業レバレッジ — 売上1%の変化 → 営業利益は何%
FY20154.53배4.53x4.53倍
FY20255.79배5.79x5.79倍
공헌이익 ÷ 영업이익Contribution ÷ operating profit限界利益 ÷ 営業利益
변동비율 여유 — 원가율이 몇 %p 오르면 적자인가Variable-cost headroom — how many pp the cost ratio can rise before a loss変動費率の余裕 — 原価率が何%pt上がると赤字か
FY20259.4%p9.4pp9.4%pt
= 영업이익률. 원료가가 판가보다 이만큼 더 오르면 고정비를 못 덮는다.= operating margin. If raw-material prices rise this much more than selling prices, fixed costs are no longer covered.= 営業利益率。原料価格が販売価格よりこれだけ多く上がると、固定費を賄えない。
FY매출Revenue売上高변동비Variable costs変動費고정비Fixed costs固定費공헌이익률Contribution margin限界利益率손익분기 매출Break-even revenue損益分岐点売上高안전마진Margin of safety安全余裕率영업 레버리지Operating leverage営業レバレッジ
20153,0751,5151,216 50.7%2,39722.1%4.53
20163,3331,6131,337 51.6%2,59122.3%4.49
20173,7961,8091,534 52.3%2,93022.8%4.39
20184,0971,9041,745 53.5%3,26120.4%4.90
20194,3872,0581,966 53.1%3,70215.6%6.40
20201,794870915 51.5%1,7770.9%105.90
20214,5372,1581,954 52.4%3,72717.8%5.60
20224,9622,4422,192 50.8%4,31613.0%7.69
20235,8142,9032,579 50.1%5,15211.4%8.78
20246,6173,0303,026 54.2%5,58115.7%6.39
20257,8463,5683,540 54.5%6,49217.3%5.79
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 고정비·변동비는 계정으로 나눈 근사이지 회사가 공시한 원가 구조가 아니다 — 매출원가 안 인건비는 변동으로, 판관비 안 운임은 고정으로 들어간다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Fixed and variable costs are an approximation split by account, not a cost structure disclosed by the company — labour costs within cost of sales count as variable and freight within SG&A as fixed.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 固定費・変動費は勘定科目で分けた近似であり、会社が開示した原価構造ではない — 売上原価中の人件費は変動費に、販管費中の運賃は固定費に入る。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

④ 발생액 — 순이익 vs 영업현금흐름Accruals — net profit vs operating cash flow発生高 — 純利益 vs 営業キャッシュ・フロー

억엔JPY 100mn億円 · Data as of 2025-08-31 · Created 2026-11-01
발생액/총자산 3년 평균Accruals/total assets, 3-year average発生高/総資産 3年平均-5.3%
순이익 > 영업현금흐름인 해Years with net profit > operating cash flow純利益 > 営業キャッシュ・フローの年3 / 11년3 / 11 years3 / 11年
누적 영업현금흐름Cumulative operating cash flow累計営業キャッシュ・フロー4,124억엔4,124 JPY 100mn4,124億円
누적 순이익Cumulative net profit累計純利益2,908억엔2,908 JPY 100mn2,908億円
발생액 = 순이익 − 영업현금흐름. 음수면 현금이 이익보다 많이 들어왔다(감가상각이 큰 장치산업의 정상 모습). 크게 양수로 돌면 이익의 질을 의심한다.Accruals = net profit − operating cash flow. A negative value means more cash came in than profit (normal for capital-intensive industries with heavy depreciation). A large swing to positive casts doubt on earnings quality.発生高 = 純利益 − 営業キャッシュ・フロー。マイナスなら利益より多くの現金が入った(減価償却の大きい装置産業では正常な姿)。大きくプラスに転じたら利益の質を疑う。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 연결 연간 값. 영업현금흐름엔 운전자본 변동이 들어 있어 원료 시차가 큰 해에 크게 흔들린다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Consolidated annual figures. Operating cash flow includes working-capital changes, so it swings widely in years with large raw-material time lags.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 連結の年次値。営業キャッシュ・フローには運転資本の増減が含まれるため、原料のタイムラグが大きい年は大きく振れる。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑤ CAPEX · FCF — 번 돈과 넣은 돈Capex · FCF — money earned and money investedCAPEX · FCF — 稼いだお金と投じたお金

억엔JPY 100mn億円 · Data as of 2025-08-31 · Created 2026-11-01
누적 설비투자 ÷ 누적 감가상각Cumulative capex ÷ cumulative depreciation累計設備投資 ÷ 累計減価償却費1.45배1.45x1.45倍
최근 3년 설비투자 ÷ 감가상각Capex ÷ depreciation, last 3 years直近3年の設備投資 ÷ 減価償却費1.44배1.44x1.44倍
누적 FCFCumulative FCF累計FCF1,945억엔1,945 JPY 100mn1,945億円
FCF 적자 연도Years with negative FCFFCFマイナスの年2019 · 2020
FCF 수익률 FY2025FCF yield FY2025FCF利回り FY20252.1%
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 설비투자는 유·무형자산 취득 현금만 — 리스로 들인 자산과 기업 인수는 빠진다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Capex covers only cash paid to acquire property, plant and equipment and intangible assets — leased assets and acquisitions are excluded.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 設備投資は有形・無形固定資産の取得による支出のみ — リースで取得した資産と企業買収は含まない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑥ 운전자본 — 매출채권 · 재고 · 매입채무 회전Working capital — receivables · inventory · payables turnover運転資本 — 売上債権・棚卸資産・仕入債務の回転

일 · 기말 잔액 기준Days · year-end balances日 · 期末残高ベース · Data as of 2025-08-31 · Created 2026-11-01
현금 전환 주기(CCC = DSO + DIO − DPO)는 FY2015 —일 → FY2025 —일 (매출채권 9 → 8일 · 재고 132 → 163일 · 매입채무 — → —일). 주기는 짧아졌다. 매출채권은 전자기록채권 포함. 재고는 매출원가 기준.The cash conversion cycle (CCC = DSO + DIO − DPO) went from — days in FY2015 to — days in FY2025 (receivables 9 → 8 days · inventory 132 → 163 days · payables — → — days). The cycle has shortened. Receivables include electronically recorded monetary claims. Inventory is measured against cost of sales.キャッシュ・コンバージョン・サイクル(CCC = DSO + DIO − DPO)はFY2015の—日 → FY2025の—日 (売上債権9 → 8日 · 棚卸資産132 → 163日 · 仕入債務— → —日)。 サイクルは短くなった。 売上債権は電子記録債権を含む。棚卸資産は売上原価ベース。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 잔액 기준이라 결산일 계절성이 섞인다. 매출채권은 전자기록채권을 포함(공시된 해)하고, 재고·매입채무는 매출원가 기준.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Based on year-end balances, so balance-sheet-date seasonality is mixed in. Receivables include electronically recorded monetary claims (in years they are disclosed); inventories and payables are measured against cost of sales.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末残高ベースのため決算日の季節性が混じる。売上債権は電子記録債権を含み(開示された年)、棚卸資産・仕入債務は売上原価ベース。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑦ ROIC · ROE · ROA — 자본에서 얼마를 버나ROIC · ROE · ROA — how much is earned on capitalROIC・ROE・ROA — 資本からどれだけ稼ぐか

% · Data as of 2025-08-31 · Created 2026-11-01
ROIC(세후 영업이익 ÷ 영업 투하자본)는 FY2015 22.1% · 고점 FY2017 27.1% · FY2025 20.6%. 영업 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유주식 포함) — 본업에 묶인 돈만 남긴다. ROE·ROA 는 기초·기말 평균 분모.ROIC (after-tax operating profit ÷ operating invested capital) was 22.1% in FY2015 · peak FY2017 27.1% · FY2025 20.6%. Operating invested capital = equity + interest-bearing debt − cash and short-term securities − investment securities (including cross-shareholdings) — leaving only the money tied up in the core business. ROE and ROA use the average of opening and closing balances as the denominator.ROIC(税引後営業利益 ÷ 営業投下資本)はFY2015 22.1% · ピークFY2017 27.1% · FY2025 20.6%。 営業投下資本 = 自己資本 + 有利子負債 − 現金・短期有価証券 − 投資有価証券(政策保有株式を含む)— 本業に拘束されたお金だけを残す。ROE・ROAは期首・期末の平均を分母とする。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 영업 투하자본에서 투자유가증권(정책보유 포함)을 뺐다 · 세율은 그해 실효세율 · 기초·기말 평균 분모라 첫 해는 기말만.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Investment securities (including cross-shareholdings) are excluded from operating invested capital · the tax rate is that year's effective rate · denominators average opening and closing balances, so the first year uses the closing balance only.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 営業投下資本から投資有価証券(政策保有株式を含む)を除いた · 税率はその年の実効税率 · 分母は期首・期末の平均のため、初年度は期末のみ。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑧ 자본 배분 — FY2015~FY2025 누적, 돈은 어디로 갔나Capital allocation — cumulative FY2015~FY2025: where did the money go資本配分 — FY2015~FY2025累計、お金はどこへ行ったか

억엔 · 현금흐름표 누계JPY 100mn · cumulative cash-flow statement億円 · キャッシュ・フロー計算書の累計 · Data as of 2025-08-31 · Created 2026-11-01
영업현금흐름Operating cash flow営業キャッシュ・フロー4,124억엔4,124 JPY 100mn4,124億円
설비투자Capex設備投資2,179억엔2,179 JPY 100mn2,179億円
주주환원(배당 + 자사주)Shareholder returns (dividends + buybacks)株主還元(配当 + 自社株買い)1,069억엔1,069 JPY 100mn1,069億円
투자주식 매각 대금Proceeds from selling investment securities投資有価証券の売却収入216억엔216 JPY 100mn216億円
순현금 변화(기말 − 기초)Change in net cash (closing − opening)ネットキャッシュの増減(期末 − 期首)42억엔42 JPY 100mn42億円
FCF 1,945억엔 vs 주주환원 1,069억엔 — 환원은 FCF 안에서 했다. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF 1,945 JPY 100mn vs shareholder returns 1,069 JPY 100mn — returns were made within FCF. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF 1,945億円 vs 株主還元1,069億円 — 還元はFCFの範囲内で行った。 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 현금흐름표 누계 — 연결 범위 변경·환율 효과·기타 재무 항목은 따로 싣지 않았다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Cumulative cash-flow-statement figures — changes in the scope of consolidation, FX effects and other financing items are not shown separately.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: キャッシュ・フロー計算書の累計 — 連結範囲の変更・為替の影響・その他の財務項目は個別に載せていない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑨ 특별손익 — 본업 밖 이익이 얼마나 받치나Extraordinary items — how much non-core profit props up earnings特別損益 — 本業以外の利益がどれだけ支えているか

억엔JPY 100mn億円 · Data as of 2025-08-31 · Created 2026-11-01
FY특별이익Extraordinary gains特別利益투자주식 매각익Gains on sale of investment securities投資有価証券売却益특별손실Extraordinary losses特別損失감손Impairment減損특별손익 ÷ 세전이익Extraordinary items ÷ pre-tax profit特別損益 ÷ 税引前利益
201512.410.24.3 1.02.4%
20167.06.76.4 3.30.2%
20170.2—8.4 4.6-1.8%
201886.486.36.1 2.914.9%
20190.20.217.9 11.8-5.1%
20200.0—186.8 142.7103.1%
202149.21.217.0 11.76.6%
20222.20.342.3 22.4-12.1%
202330.529.654.4 49.0-7.1%
2024100.2—58.8 43.56.9%
20253.8—67.2 50.0-9.6%
FY2015~FY2025 투자주식 매각익 누계 134억엔 = 누적 순이익 2,908억엔의 4.6%(세전 기준이라 상한). 최근 3년 특별손익 ÷ 세전이익 평균 -3.3%.Cumulative gains on sale of investment securities FY2015~FY2025: 134 JPY 100mn = 4.6% of cumulative net profit of 2,908 JPY 100mn (pre-tax basis, so an upper bound). Average extraordinary items ÷ pre-tax profit over the last 3 years: -3.3%.FY2015~FY2025の投資有価証券売却益の累計134億円 = 累計純利益2,908億円の4.6%(税引前ベースのため上限)。直近3年の特別損益 ÷ 税引前利益の平均-3.3%。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 특별손익은 일본기준 손익계산서 구분 그대로 · 특별 제외 순이익은 그해 실효세율로 세후 환산한 근사.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Extraordinary items follow the Japan GAAP income-statement classification · net profit excluding extraordinary items is an approximation converted to after-tax at that year's effective tax rate.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 特別損益は日本基準の損益計算書の区分のまま · 特別損益除く純利益はその年の実効税率で税引後に換算した近似。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑩ 장부 점검 게이지 — 5개 플래그Accounting check gauges — 5 flags帳簿点検ゲージ — 5個のフラグ

빨강 0 · 주황 0 · 최근 연도 기준Red 0 · amber 0 · latest year赤0 · 橙0 · 直近年度ベース · Data as of 2025-08-31 · Created 2026-11-01
이익−현금 괴리(발생액/총자산, 3년 평균)Profit–cash gap (accruals/total assets, 3-year average)利益と現金の乖離(発生高/総資産、3年平均)
-5.3%-5.3%-5.3% · 기준 5%· threshold 5%· 基準5%
순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).
매출채권 증가 − 매출 증가(최근 연도)Receivables growth − revenue growth (latest year)売上債権の増加 − 売上高の増加(直近年度)
-11.3%-11.3%-11.3% · 기준 10%· threshold 10%· 基準10%
채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.
재고 증가 − 매출 증가(최근 연도)Inventory growth − revenue growth (latest year)棚卸資産の増加 − 売上高の増加(直近年度)
-8.2%-8.2%-8.2% · 기준 10%· threshold 10%· 基準10%
재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).
특별손익 ÷ 세전이익(3년 평균)Extraordinary items ÷ pre-tax profit (3-year average)特別損益 ÷ 税引前利益(3年平均)
-3.3%-3.3%-3.3% · 기준 20%· threshold 20%· 基準20%
투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.
설비투자 ÷ 감가상각(3년) vs 매출 연성장Capex ÷ depreciation (3 years) vs annual revenue growth設備投資 ÷ 減価償却費(3年)vs 売上高の年成長率
1.44배1.44x1.44倍 · 기준 2.0배· threshold 2.0x· 基準2.0倍
상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 16.5%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 16.5%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 16.5%.

⑪ 밸류에이션 — P/B · P/E · EV/EBITDAValuation — P/B · P/E · EV/EBITDAバリュエーション — P/B・P/E・EV/EBITDA

배 · 기말 주가는 가공값x · year-end prices are derived values倍 · 期末株価は加工値 · Data as of 2025-08-31 · Created 2026-11-01
FY시가총액(억엔)Market cap (JPY 100mn)時価総額(億円)P/BP/EEV/EBITDA배당수익률Dividend yield配当利回りFCF 수익률FCF yieldFCF利回り순현금 ÷ 시총Net cash ÷ market capネットキャッシュ ÷ 時価総額투자유가증권 ÷ 시총Investment securities ÷ market cap投資有価証券 ÷ 時価総額
2015——28.1 ——%—% —%—%
20166,2754.1024.4 13.51.23%1.4% 4.4%1.7%
20179,6155.6631.9 17.50.94%3.6% 5.1%1.3%
20186,9393.6420.5 12.21.47%0.8% 7.7%0.6%
20193,8881.9116.7 7.513.54%-1.0% 0.3%1.1%
2020——— ——%—% —%—%
20216,2012.9218.3 10.21.70%7.1% 4.2%0.8%
20223,4281.4213.9 6.53.08%2.2% 4.0%1.3%
20234,9671.8822.5 9.12.13%6.7% 3.9%0.3%
20247,2572.4817.4 8.81.46%3.3% 4.6%0.3%
202516,9135.1033.2 16.81.57%2.1% 1.9%0.2%
시가총액 = 기말 주가(가공) × (발행주식 − 자기주식). EV = 시가총액 + 이자부채(리스 포함) − 현금·단기유가증권. 투자유가증권(정책보유 포함)은 EV 에서 빼지 않았다 — 표의 마지막 열이 그 크기다.Market cap = year-end price (derived) × (shares issued − treasury shares). EV = market cap + interest-bearing debt (including leases) − cash and short-term securities. Investment securities (including cross-shareholdings) are not deducted from EV — the last column of the table shows their size.時価総額 = 期末株価(加工値)×(発行済株式数 − 自己株式数)。EV = 時価総額 + 有利子負債(リースを含む)− 現金・短期有価証券。投資有価証券(政策保有株式を含む)はEVから差し引いていない — 表の最終列がその大きさだ。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 주가는 그해 有報의 EPS × PER 로 역산한 가공값 — 시장 주가 원천을 쓰지 않았다. 적자 해는 PER 미기재로 빈칸.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Year-end share prices are derived values back-calculated as EPS × P/E from that year's annual securities report — no market price source is used. Loss years are blank because P/E is not reported.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末株価はその年の有報のEPS × PERから逆算した加工値 — 市場の株価データは使っていない。赤字の年はPER記載なしのため空欄。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑫ P/E 냐 P/B 냐 — 이 주가는 무엇을 따라가나P/E or P/B — what does this share price track?P/EかP/Bか — この株価は何に連動するか

有報 5년 표 FY2012~FY20255-year tables in the annual securities reports FY2012~FY2025有報の5年表 FY2012~FY2025 · Data as of 2025-08-31 · Created 2026-11-01
이 종목 · 그해 이익 기준This stock · same-year earningsこの銘柄 · その年の利益ベース
β 1.50
log(P/B) 를 log(ROE) 에 회귀한 기울기(±0.36, 13년). 1 이면 ROE 가 변해도 P/E 가 그대로(이익을 따라감), 0 이면 P/B 가 그대로(장부에 묶임). → 이익(P/E)을 따라간다.Slope from regressing log(P/B) on log(ROE) (±0.36, 13 years). 1 means P/E stays put as ROE changes (tracks earnings); 0 means P/B stays put (anchored to book). → tracks earnings (P/E).log(P/B)をlog(ROE)に回帰した傾き(±0.36、13年)。1ならROEが変わってもP/Eは不変(利益に連動)、0ならP/Bが不変(簿価に縛られる)。→ 利益(P/E)に連動する。
이 종목 · 3년 평균 이익 기준This stock · 3-year average earningsこの銘柄 · 3年平均利益ベース
β 0.65
일시 이익은 주가에 안 실린다(일회성이면 P/E 가 반대로 움직인다). 3년 평균 EPS 로 바꿔 다시 잰 값(±0.31, 11년) → 평탄화 이익(3년 평균)으로 보면 둘 사이.One-off profits are not priced in (if a profit is one-off, P/E moves the other way). Re-measured with 3-year average EPS (±0.31, 11 years) → in between on smoothed earnings (3-year average).一時的な利益は株価に織り込まれない(一過性ならP/Eが逆に動く)。3年平均EPSに替えて測り直した値(±0.31、11年) → 平準化利益(3年平均)で見ると両者の中間。
P/B 변화 분해 FY2012→FY2025Decomposition of P/B change FY2012→FY2025P/B変化の分解 FY2012→FY2025
+108%
log(P/B) 변화 = log(ROE) +27% + log(P/E) +81%. P/B 범위 1.42~5.66배 · 표준편차(log) P/E 0.30 vs P/B 0.44.Change in log(P/B) = log(ROE) +27% + log(P/E) +81%. P/B range 1.42~5.66x · standard deviation (log) P/E 0.30 vs P/B 0.44.log(P/B)の変化 = log(ROE) +27% + log(P/E) +81%。P/Bの範囲1.42~5.66倍 · 標準偏差(log)P/E 0.30 vs P/B 0.44。
일본 시장 표본 369사 · 회사 안 시계열Japan market sample, 369 companies · within-company time series日本市場の標本369社 · 企業内の時系列
β 0.15
같은 회귀를 369사(3443개 회사-연도)에 — 3년 평균 이익 기준 β 0.18. 회사별 β 중앙값 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.The same regression across 369 companies (3443 company-years) — β on 3-year average earnings 0.18. Median company β 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.同じ回帰を369社(3443の企業・年度)に — 3年平均利益ベースのβ 0.18。企業別βの中央値0.22。그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.
점 하나 = 한 해(그해 ROE = EPS ÷ BPS, P/B = PER × EPS ÷ BPS — 둘 다 같은 有報 5년 표의 같은 주식 기준이라 분할·병합에 무관). 적자 해는 PER 이 비어 빠진다(1년).Each dot = one year (ROE that year = EPS ÷ BPS, P/B = P/E × EPS ÷ BPS — both on the same share basis from the same 5-year table in the annual securities report, so unaffected by splits and consolidations). Loss years have no P/E and are excluded (1 years).点1つ = 1年(その年のROE = EPS ÷ BPS、P/B = PER × EPS ÷ BPS — どちらも同じ有報5年表の同じ株式ベースのため、分割・併合の影響を受けない)。赤字の年はPERが空欄のため除外(1年)。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 한 회사의 연간 관측이라 표본이 작다(표준오차를 함께 적었다) · 적자 해는 빠진다 · 평탄화 이익은 그해 포함 직전 연도들의 EPS/BPS 평균.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Annual observations of a single company, so the sample is small (standard errors are shown alongside) · loss years are excluded · smoothed earnings are the average EPS/BPS of the preceding years including that year.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の株式会社良品計画提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 1社の年次観測のため標本が小さい(標準誤差を併記した)· 赤字の年は除外 · 平準化利益はその年を含む直近数年のEPS/BPSの平均。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑬ 측정 한계Measurement limitations測定の限界

1고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.
2이 페이지는 有価証券報告書(연간)만 쓴다 — 분기·반기 손익은 싣지 않았다.이 페이지는 有価証券報告書(연간)만 쓴다 — 분기·반기 손익은 싣지 않았다.이 페이지는 有価証券報告書(연간)만 쓴다 — 분기·반기 손익은 싣지 않았다.
3기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.
4ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).

같이 볼 페이지Related pages併せて見るページ

유통 — 편의점(세븐일레븐)·슈퍼Retail — convenience stores (7-Eleven), supermarkets小売 — コンビニ(セブン-イレブン)・スーパー세븐&아이 · セブン&アイ・ホールディングスSeven & i Holdings · セブン&アイ・ホールディングスセブン&アイ・ホールディングス유통 — 종합슈퍼(GMS)·쇼핑몰·금융Retail — GMS, shopping malls, financial services小売 — 総合スーパー(GMS)・ショッピングモール・金融이온 · イオンAEON · イオンイオン유통 — 의류 SPA(유니클로·GU)Retail — apparel SPA (UNIQLO, GU)小売 — 衣料品SPA(ユニクロ・GU)패스트리테일링(유니클로) · ファーストリテイリングFast Retailing · ファーストリテイリングファーストリテイリング유통 — 디스카운트 스토어(돈키호테)Retail — discount stores (Don Quijote)小売 — ディスカウントストア(ドン・キホーテ)PPIH(돈키호테) · パン・パシフィック・インターナショナルホールディングスPan Pacific International Holdings · パン・パシフィック・インターナショナルホールディングスパン・パシフィック・インターナショナルホールディングス유통 — 가구·인테리어 SPARetail — furniture & home furnishing SPA小売 — 家具・インテリアSPA니토리 · ニトリホールディングスNitori Holdings · ニトリホールディングスニトリホールディングス유통 — 백화점Retail — department stores小売 — 百貨店미쓰코시이세탄 · 三越伊勢丹ホールディングスIsetan Mitsukoshi Holdings · 三越伊勢丹ホールディングス三越伊勢丹ホールディングス 일본 시장 표본Japan market sample日本市場の標本P/E 냐 P/B 냐P/E or P/BP/EかP/Bか